(Q35199637)

7 August 2017

1 reference

title

Antipsychotic drugs and QT interval prolongation (English)

1 reference

7 August 2017

1

Wojciech Zareba

1 reference

7 August 2017

David A Lin

2

1 reference

7 August 2017

publication date

1 January 2003

1 reference

7 August 2017

published in

Psychiatric Quarterly

1 reference

7 August 2017

volume

74

1 reference

7 August 2017

issue

3

1 reference

7 August 2017

page(s)

291-306

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1024122706337

7 August 2017

exact match

0 references

cites work

ISHNE guidelines for electrocardiographic evaluation of drug-related QT prolongation and other alterations in ventricular repolarization: task force summary. A report of the Task Force of the International Society for Holter and Noninvasive Electroc

1 reference

12 December 2020

Electrocardiographic changes and cardiac arrhythmias in patients receiving psychotropic drugs

1 reference

12 December 2020

The association between intravenous haloperidol and Torsades de Pointes. Three cases and a literature review

1 reference

12 December 2020

Risk of cardiac events in family members of patients with long QT syndrome.

1 reference

12 December 2020

Sudden death in patients receiving clozapine treatment: a preliminary investigation

1 reference

12 December 2020

Unique topographical distribution of M cells underlies reentrant mechanism of torsade de pointes in the long-QT syndrome

1 reference

12 December 2020

An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study)

1 reference

12 December 2020

Sex differences in the evolution of the electrocardiographic QT interval with age

1 reference

12 December 2020

The long QT syndromes: genetic basis and clinical implications

1 reference

12 December 2020

Drug-induced QT prolongation in women during the menstrual cycle

1 reference

12 December 2020

A common polymorphism associated with antibiotic-induced cardiac arrhythmia

1 reference

12 December 2020

Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data

1 reference

12 December 2020

The QT interval and torsade de pointes

1 reference

12 December 2020

A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs

1 reference

12 December 2020

Studies on the mechanism of a fatal clarithromycin-pimozide interaction in a patient with Tourette syndrome

1 reference

12 December 2020

Acquired long QT syndromes and the risk of proarrhythmia

1 reference

12 December 2020

Torsades de pointes occurring in association with terfenadine use

1 reference

12 December 2020

The risk of serious cardiac arrhythmias among cisapride users in the United Kingdom and Canada

1 reference

12 December 2020

Relation between QT intervals and heart rates from 40 to 120 beats/min in rest electrocardiograms of men and a simple method to adjust QT interval values.

1 reference

12 December 2020

THIORIDAZINE HYDROCHLORIDE (MELLARIL): ITS EFFECT ON THE ELECTROCARDIOGRAM AND A REPORT OF TWO FATALITIES WITH ELECTROCARDIOGRAPHIC ABNORMALITIES

1 reference

12 December 2020

Torsades de pointes associated with chlorpromazine: case report and review of associated ventricular arrhythmias.

1 reference

12 December 2020

The long QT syndrome. Prospective longitudinal study of 328 families

1 reference

12 December 2020

A survey of sudden death associated with the use of antipsychotic or antidepressant drugs: 49 cases in Finland

1 reference

12 December 2020

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

1 reference

12 December 2020

Influence of the genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group.

1 reference

12 December 2020

Antipsychotics and the risk of sudden cardiac death

1 reference

12 December 2020

Haloperidol-induced torsades de pointes

1 reference

12 December 2020

Electrocardiographic changes in patients receiving neuroleptic medication.

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1024122706337

1 reference

Dimensions Publication ID

7 August 2017

1014281531

0 references

1 reference